Sunday, April 27, 2025
HomeNews

News

DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura

IVERIC bio, Inc. and DelSiTech Ltd, announced an exclusive global license agreement providing Iveric Bio with the right to develop and commercialize new formulations...

Intravacc and DZNE Awarded EU Funding to Develop Vaccine Against Genetic ALS Variant

Intravacc, a world leading contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines and the German Center for Neurogenerative Diseases (DZNE), have...

Inactivation of Suv39h1 Enhances Anti-Tumor Immune Response by Increasing T Cell Activity

Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, today announced a publication in Nature Communications demonstrating that the histone lysine methyltransferase enzyme Suv39h1 plays...

ClearMind Biomedical Clears FIM Clinical Trial for Least Invasive ICH Treatment to Date

ClearMind Biomedical's novel neurosurgical endoscope, the Axonpen System, has completed its First in Man (FIM) clinical trial in Taiwan with outstanding results. The Axonpen System...

Billion-Euro Market Biotechnology: Exyte Builds mRNA Competence Center for WACKER in Halle

Exyte GmbH (Exyte), a global leader in the design, engineering and delivery of facilities for high-tech industries, is building a mRNA competence center at...
0FansLike
0FollowersFollow
spot_img

Hot Topics